De Novo
DEN160016: Variola virus Real-Time PCR Assay
FDA De Novo · centers for disease control and prevention (cdc) · decided Feb 6, 2017
Key facts
| De Novo number | DEN160016 |
|---|---|
| Device name | Variola virus Real-Time PCR Assay |
| Applicant | centers for disease control and prevention (cdc) |
| Product code | PRA |
| Date received | Apr 14, 2016 |
| Decision date | Feb 6, 2017 |
| Decision | granted (DENG) |
| FDA classification | Class II |
| Review panel | Microbiology |
| FEI number | 1050190 |
At a glance
- None Later 510(k)s citing this De Novo
- None UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: